BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 2002
View Archived Issues
Pharming and GTC enter crosslicense agreement
Read More
Schering AG and Neurosciences Victoria sign neuroscience research collaboration
Read More
Pharmacopeia identifies lead series of compounds in Organon collaboration
Read More
Snapshots on thiazolidinediones at ENDO 2002
Read More
Novel antiplatelet agent discovered and characterized at Yamanouchi
Read More
Ro-25-4020: mechanism underlying enhanced anticancer properties compared to 1,25(OH)2D3
Read More
ACAT inhibitor with promising hypocholesterolemic effects under investigation at Sumitomo
Read More
Dual alpha/beta-adrenoceptor blocker and vasodilator characterized by Chinese group
Read More
The lipid-lowering effects of a combination of raloxifene and simvastatin
Read More
New oxytocin antagonists reported by Mitsubishi Pharma
Read More
Almirall Prodesfarma claims novel antihistaminic compounds
Read More
Adenovirus-mediated Apoptin gene transfer specifically kills tumor cells
Read More
Novel 5-HT2C agonists for use in obesity and psychiatric disorders
Read More
TPP-II inhibitors in early development at Janssen
Read More
Researchers at Allergan identify inhibitors of P-450RAI
Read More
Merck presents new alpha1A-adrenoceptor antagonists for BPH
Read More
Inhibitors of gamma-secretase in development at Merck & Co.
Read More
Nonsteroidal SERM with antiestrogenic effects in breast cancer cells, little uterotrophic liability
Read More
CPMP issues positive opinion reaffirming favorable risk/benefit profile of Reductil/Meridia
Read More
Noven files MethyPatch NDA for ADHD
Read More
Esperion initiates phase II study of ETC-588 in vascular disease
Read More
Calcimimetic AMG-073 may improve outcomes in patients with ESRD
Read More
Periostat receives final marketing approvals in Portugal and The Netherlands
Read More
Tariquidar enters phase III for multidrug-resistant NSCLC
Read More
Phase I/II follow-up data for GVAX lung cancer vaccine
Read More
Zevalin European launch delayed
Read More